Global Platelet Aggregation Devices Market is expected to grow at a CARG of 22% during the forecast period 2020-2027
A new research report published by Fior Markets with the title Platelet Aggregation Devices Market By Type (Consumables & Accessory, System, Reagent), Application (Research Application, Clinical Application), End-User, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, And Forecast 2020 To 2027.
The global platelet aggregation devices market is expected to grow from USD 235.04 million in 2019 to USD 279.73 million by 2027, at a CARG of 22% during the forecast period 2020-2027. North American region is the leading market, because of strong presence of devices manufacturers, growing number of surgical procedures, rising awareness among healthcare professionals regarding the benefit proposed by PAT in disease diagnosis and large patient population for target disease.
Also, factors such like increasing prevalence of orthopedic, bleeding disorders and urological and large number of patients undergoing cardiovascular surgeries are the factors predicted to sustain the market leader status of North America backed by high growth rate.
NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.
DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/418706/request-sample
The key players of this market are Sysmex Corp., Accriva Diagnostics, Bio/Data Corp., Haemonetics Corp., Aggredyne, Siemens AG, Sentinel CH. S.p.A., Halena Laboratories, Tem Group.
The type segment includes consumable & accessory, system and reagent. The system segment has the highest share. The application segment includes research application and clinical application. The end-user segment includes diagnostic laboratories, standalone hospitals, research & academic institutes and others. Standalone hospitals have the largest share, due to the factors like enhanced healthcare infrastructure, larger patient pool and availability of skilled technicians.
The increasing number of platelet disorders like increasing popularity of platelet therapy for cancer patients, rapid technological advancement and thrombocythemia are the major factors which fuel up the platelet aggregation devices market. additionally, rising geriatric population and rising prevalence of chronic diseases are driving the market growth.
However, high cost of devices and lack of sufficient technical expertise are the major restraining factors for the platelet aggregation devices market.
About the report:
The global platelet aggregation devices market is analyzed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on firstname.lastname@example.org or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
- CDN Newswire